Anti-tumor effect of Liqi, a traditional Chinese medicine prescription, in tumor bearing mice

BMC Complementary and Alternative Medicine

Volumn 9, Issue , 2009, Pages

  Ji, Deng Bo ^a   Ye, Jia ^a   Jiang, Yi Min ^b   Qian, Bo Wen ^c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; INTERLEUKIN 2; PROSTACYCLIN; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA;

ANGIOSPERM; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECT; FEMALE; LEWIS CARCINOMA; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MOUSE; NATURAL KILLER CELL; NUDE MOUSE; PHYTOTHERAPY; SARCOMA; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTE AGGREGATION; TUMOR CELL LINE;

ANGIOSPERMS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, LEWIS LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; EPOPROSTENOL; FEMALE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; PHYTOTHERAPY; PLATELET AGGREGATION; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTE SUBSETS; THROMBOXANE A2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350032153     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-9-20     Document Type: Article

References (34)

1. Kellof GJ. Perspective on cancer chemoprevention research and drug development. Adv Cancer Res 2000, 78:199-334.
2. Xu GH, Kim JA, Kim SY, Ryu J, Kim YS, Jung SH, Kim MK, Lee SH. Terpenoids and Coumarins Isolated from the Fruits of Poncirus trifoliata. Chem Pharm Bull 2008, 56:839-842.
3. Mimaki Y, Kttroda M, Yokosuka A. Triterpenes and triterpene saponins from the stems of Akebia Trifoliate. Chem Pharm Bull 2003, 51:960.
4. Gao Y, Huang H, Xu H, Diao Y, Dong Z. Studies on the chemical constituents of Citrus medica var. sarcodactylis. Zhong Yao Cai 2002, 25:639-640. (In Chinese).
5. Talwar KK, Singh IP, Kalsi PS. A sesquiterpenoid with plant growth regulatory activity from Saussurea lappa. Phytochemistry 1992, 31:336-338.
6. Jayaprakasha GK, Mandadi KK, Poulose SM, Jadegoud Y, Nagana Gowda GA, Patil BS. Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Bioorg Med Chem 2007, 15:4923-4932.
7. Yi JM, Kim MS, Koo HN, Song BK, Yoo YH, Kim HM. Poncirus trifoliata fruit induces apoptosis in human promyelocytic leukemia cells. Clin Chim Acta 2004, 340:179-185.
8. Loo WT, Chen JP, Chow LW, Chou JW. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro. Biomed Pharmacother 2007, 61:601-605.
9. Ko SG, Kim HP, Jin DH, Bae HS, Kim SH, Park CH, Lee JW. Saussurea lappa induces G2-growth arrest and apoptosis in AGS gastric cancer cells. Cancer Lett 2005, 220:11-19.
10. Sun GP, Wang H, Xu SP, Shen YX, Wu Q, Chen Z, Wei W. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-α production. Eur J Pharmacol 2008, 584:246-252.
11. Li C, Kumar S, Ponting J, Carette M, Allan E. Glucosaminylmuramyl dipeptide (GMDP) modulates endothelial cell activities in vitro but has no effects on angiogenesis in vivo. Inflamm Res 1997, 46:348-353.
12. Zhang LL, Wei W, Yan S, Hu XY, Sun WY. Therapeutic effects of glucosides of Cheanomeles speciosa on collagen-induced arthritis in mice. Acta Pharmacol Sin 2004, 25:1495-1501.
13. Sarangi I, Ghosh D, Bhutia SK, Mallick SK, Maiti TK. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int Immunopharmacol 2006, 6:1287-1297.
14. Wang YP, Li XY, Song C, Hu ZB. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 2002, 23:263-266.
15. Kunita A, Kashima TG, Morishita Y, Fukayama M, Kato Y, Tsuruo T, Fujita N. The Platelet Aggregation-Inducing Factor Aggrus/Podoplanin Promotes Pulmonary Metastasis. Am J Pathol 2007, 170:1337-1347. 1829466, 17392172.
16. Furhashi N, Tsujiei M, Kimura H, Yajima A, Nagae H, Kimura C. Maternal and fetal atrial natriuretic peptide levels, maternal plasma rennin activity, angiotensin II, prostacyclin and thromboxane A2 levels in normal and preeclamptic pregnancies. Tohoku J Exp Med 1991, 165:79-86.
17. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med 1998, 188:2357-2368. 2212434, 9858522.
18. Nishimura T, Iwakabe K, Sekimoto M, Ohmi Y, Yahata T, Nakui M, Sato T, Habu S, Tashiro H, Sato M, Ohta A. Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. J Exp Med 1999, 190:617-627. 2195611, 10477547.
19. van den Broek MF, Kagi D, Zinkernagel RM, Hengartner H. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur J Immnol 1995, 25(11):3514-3516. 8566046.
20. Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA. Perforin is a major contributor to NK cell control of tumor metastasis. J Immunol 1999, 162:6658-6662.
21. Varalakshmi C, Ali AM, Pardhasaradhi BVV, Srivastava RM, Singh S, Khar A. Immunomodulatory effects of curcumin: In-vivo. Int Immunopharmacol 2008, 8:688-700.
22. Tamada K, Chen L. Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules. Cancer Immunol Immunother 2006, 55:355-362.
23. Glick RP, Lichtor T, Lin H, Tarlock K, Cohen EP. Immunogene therapy as a treatment for malignant brain tumors in youngmice. J Neurosurg 2006, 105:65-70.
24. Antony PA, Restifo NP. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. J Immunother 2005, 28:120-128. 1242172, 15725955.
25. Haranaka K, Satomi N, Sakurai A. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 1984, 34:263-267.
26. Rychly J, Knippel E, Krygier-Stojalowska A, Nizze H, Kuchnio M, Kraeft SK. DNA cytometric and histologic findings in mouse tumors(BP and S180) with different response to treatment with tumor necrosis factor. Acta Oncol 1990, 29:47-51.
27. Su Y, Wu YM. The study of synergistic cytotoxicity of tumor necrosis factor and interleukin-2 against lung adenocarcinoma cell. Chin J Cancer Res 2000, 19:779-781.
28. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship?. Cancer Metastasis Rev 1992, 11:325-351.
29. Philippe C, Philippe B, Fouqueray B, Perez J, Lebret M, Baud L. Protection from tumor necrosis factor-mediated cytolysis by platelets. Am J Pathol 1993, 143:1713-1723. 1887257, 8256858.
30. Mehta P. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1984, 63:55-63.
31. Verheul HM, Hoekman K, Lupu F, Broxterman HJ, Valk P, Kakkar AK, Pinedo HM. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 2000, 6:166-171.
32. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita JK, Katagiri H, Majima M, Yokode M, Kita T, Narumiya S. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 2004, 114:784-794. 516261, 15372102.
33. Keith RL, Miller YE, Hoshikawa Y, Moore MD, Gesell TL, Gao B, Malkinson AM, Golpon HA, Nemenoff RA, Geraci MW. Manipulation of Pulmonary Prostacyclin Synthase Expression Prevents Murine Lung Cancer. Cancer Res 2002, 62:734-740.
34. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002, 296:539-541.